Murali M Chakinala MD
Critical Care Medicine, Pulmonary Vascular Medicine
Associate Professor, Internal Medicine, Washington University School of Medicine
Join to View Full Profile
4921 Parkview PlFl 8St. Louis, MO 63110
Phone+1 314-454-8917
Fax+1 314-454-5571
Dr. Chakinala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Murali Chakinala is a pulmonologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Barnes-Jewish West County Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 23 years. He specializes in pulmonary vascular diseases, thromboembolic disease and general pulmonology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1994 - 1998
Vanderbilt University School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2022 - 2026
MO State Medical License 2000 - 2026
TX State Medical License 1996 - 1999
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Top Doctors 2021-2024
- Best Doctors in America 2011-2020
- Outstanding Physician of the Year Pulmonary Hypertension Association, 2014
Clinical Trials
- Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2010 Apr 08
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.Harrison W Farber, Murali M Chakinala, Anna R Hemnes, Kelly M Chin, Kristin B Highland
Journal of Racial and Ethnic Health Disparities. 2025-08-04 - 1 citationsSafety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist.Ali Ataya, James C Coons, Natalie Patzlaff, Meredith Broderick, Scott Seaman
JHLT Open. 2025-08-01 - Corrigendum to ''Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from ...Vallerie McLaughlin, Harrison W Farber, Kristin B Highland, Anna R Hemnes, Murali M Chakinala
The Journal of Heart and Lung Transplantation. 2025-08-01
Press Mentions
PAH Care Turns Corner with New Therapies, Intensified MonitoringFebruary 8th, 2022
A Deep Dive into Pulmonary HypertensionJanuary 21st, 2019
PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial HypertensionNovember 27th, 2018- Join now to see all
Grant Support
- Impact Of Community-Acquired Respiratory Viral Infecions In Lung TransplantNational Center For Research Resources2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
